Business Description
Compare
Compare
Traded in other countries / regions
INVICTA.India IPO Date
2025-12-08Description
Invicta Diagnostic Ltd is engaged in the business of medical and diagnostic services and operates diagnostic centres providing medical testing and allied healthcare services in the Mumbai Metropolitan Region. The Company runs a diagnostic chain comprising seven diagnostic centres and one centralised laboratory across MMR in Maharashtra and operates under a hub and spoke model with a flagship hub in Thane, additional hub centres, spoke centres, and a centralised laboratory. Its service offerings include radiology and imaging, pathology and clinical laboratory tests, teleradiology, and services such as ultrasound, X Ray, CT scan, MRI scan, PET scan, and cardiac diagnostics, with patient convenience supported through home sample collection, house calls, and multiple report delivery options.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.05 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.35 | |||||
Interest Coverage | 33.36 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 6.8 | |||||
Beneish M-Score | 3.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.99 | |||||
9-Day RSI | 42.87 | |||||
14-Day RSI | 46.7 | |||||
3-1 Month Momentum % | -18.32 | |||||
6-1 Month Momentum % | -1.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.79 | |||||
Quick Ratio | 4.71 | |||||
Cash Ratio | 3.1 | |||||
Days Inventory | 74.02 | |||||
Days Sales Outstanding | 17.75 | |||||
Days Payable | 283.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -32.68 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 91.58 | |||||
Operating Margin % | 20.14 | |||||
Net Margin % | 15.17 | |||||
EBITDA Margin % | 32.3 | |||||
FCF Margin % | -31 | |||||
OCF Margin % | 9.06 | |||||
ROE % | 16.51 | |||||
ROA % | 12.65 | |||||
ROIC % | 16.46 | |||||
ROC (Joel Greenblatt) % | 45.12 | |||||
ROCE % | 21.47 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.53 | |||||
PE Ratio without NRI | 17.53 | |||||
PS Ratio | 2.59 | |||||
PB Ratio | 1.76 | |||||
Price-to-Tangible-Book | 1.75 | |||||
Price-to-Operating-Cash-Flow | 32.05 | |||||
EV-to-EBIT | 9.58 | |||||
EV-to-EBITDA | 6.6 | |||||
EV-to-Revenue | 2.13 | |||||
EV-to-FCF | -7.3 | |||||
Price-to-Graham-Number | 1.17 | |||||
| Price-to-Net-Current-Asset-Value | 3.65 | |||||
| Price-to-Net-Cash | 7.36 | |||||
Earnings Yield (Greenblatt) % | 10.43 | |||||
FCF Yield % | -11.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Invicta Diagnostic Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 323.536 | ||
| EPS (TTM) (₹) | 3.972 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 46.7 | ||
| 14-Day ATR (₹) | 2.478525 | ||
| 20-Day SMA (₹) | 71.485 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 58.1 - 105 | ||
| Shares Outstanding (Mil) | 12.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Invicta Diagnostic Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Invicta Diagnostic Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Invicta Diagnostic Ltd Frequently Asked Questions
What is Invicta Diagnostic Ltd(NSE:INVICTA)'s stock price today?
The current price of NSE:INVICTA is ₹69.65. The 52 week high of NSE:INVICTA is ₹105.00 and 52 week low is ₹58.10.
When is next earnings date of Invicta Diagnostic Ltd(NSE:INVICTA)?
The next earnings date of Invicta Diagnostic Ltd(NSE:INVICTA) is .
Does Invicta Diagnostic Ltd(NSE:INVICTA) pay dividends? If so, how much?
Invicta Diagnostic Ltd(NSE:INVICTA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Invicta Diagnostic Ltd
No articles.